Low income (World Bank) vs Saudi Arabia: Pneumococcal conjugate second or third-dose vaccines (PCVc)

Low income (World Bank)
68.0%
in 2025
Saudi Arabia
98.0%
in 2025
Low income (World Bank) rank
8th
Saudi Arabia rank
11th

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • Low income (World Bank)
  • Saudi Arabia
020406080100200820162025

How they compare

Saudi Arabia currently reports 98.0% against 68.0% in Low income (World Bank), a difference of 30.0%.

That makes Saudi Arabia's figure about 1.4 times Low income (World Bank)'s.

Across all 18 years both countries report, Saudi Arabia has been ahead every year.

Low income (World Bank) ranks 8th and Saudi Arabia ranks 11th of 11 groups.

Saudi Arabia has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Low income (World Bank) Saudi Arabia Difference Ahead
2000s 0.0% 49.0% 49.0% Saudi Arabia
2010s 44.8% 97.8% 53.0% Saudi Arabia
2020s 64.0% 96.8% 32.8% Saudi Arabia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Low income (World Bank) or Saudi Arabia?
Saudi Arabia, at 98.0% against 68.0% in Low income (World Bank) as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Low income (World Bank) and Saudi Arabia?
30.0%, with Saudi Arabia ahead.
How many years of comparable data are there for Low income (World Bank) and Saudi Arabia?
18 years are reported by both, from 2008 to 2025.
How do Low income (World Bank) and Saudi Arabia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Low income (World Bank) ranks 8th and Saudi Arabia ranks 11th of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Low income (World Bank) vs Saudi Arabia: Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 03 September 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/low-income-world-bank/saudi-arabia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/low-income-world-bank/saudi-arabia/">Low income (World Bank) vs Saudi Arabia: Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 3,723 data points, 2008–2025
Last refreshed